CHI3L1 and neoplasm: CHI3L1 has been proposed both as a biomarker and a potential therapeutic target in gastric and colorectal cancer, being overexpressed in serum and tumor tissue17–20 being involved in promoting cancer cell proliferation, invasion and metastasis21.